Release date: December 1, 2006
Available for credit through: December 31, 2007
Program Description
Physicians face unique diagnostic and treatment challenges when treating patients with seizures. Primary care physicians may not be familiar with current treatment options and clinical trial evidence supporting newer first-line agents. In the emergency setting, the evaluation and treatment of a patient with seizures depends upon whether the patient has a history of epilepsy or is presenting with his or her first seizure. Emergency health physicians must decide what level of treatment (i.e., very aggressive, less aggressive) is appropriate. In order to make effective treatment decisions, these clinicians need to understand published clinical guidelines or treatment algorithms and evidence from clinical trials both in and outside of the US. This program features a distinguished panel of experts sharing clinical experiences and suggesting strategies for treating patients with epilepsy with a focus on primary care and emergency treatment.
Target Audience
The target audience for this activity includes primary care physicians, neurologists, and emergency/critical care physicians who care for patients with epilepsy.
Educational Objectives
Upon completion of this educational activity participants will be able to:
Discuss the efficacy and safety of newer AEDS in various types of epilepsy, including evidence from US and non-US clinical trials
Summarize pharmacokinetic data available for AEDs, including any comparison data
Review general diagnostic and therapeutic considerations for primary care physicians
Identify available agents for use in the emergency room setting
The views and opinions expressed in this activity are those of the faculty. They do not reflect the views of UCB, any other manufacturer of pharmaceuticals, or ArcMesa Educators.
The recommendations made in this program are based upon a combination of randomized clinical trials, current guidelines, and the clinical practice experience of the participating panelists. Any medications, diagnostic procedures or treatments discussed by the panelists should not be utilized without evaluation of their patient's conditions. Participants are urged to consult the full prescribing information on any drug mentioned in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication.
Printer settings may vary. Please use landscape layout option.
Blaise F. D. Bourgeois, MD Professor of Neurology
Harvard Medical School
Director, Division of Epilepsy and Clinical Neurophysiology
Children's Hospital
Boston, MA
Faculty
Edward P. Sloan, MD, MPH
Professor
Department of Emergency Medicine
University of Illinois College of Medicine
Chicago, IL
Barry E. Gidal, PharmD, RPh
Professor of Pharmacy and Neurology
School of Pharmacy and Department of Neurology
University of Wisconsin
Madison, WI
Andres M. Kanner, MD Professor of Neurological Sciences and Psychiatry
Rush Medical College
Director, Laboratory of Electroencephalography and Video-EEG-Telemetry
Rush University Medical Center
Chicago, IL
